Analyst
Bank of America
Equibles does not estimate personal net worth.
Alex Janahan is recorded as Analyst at Bank of America. Alex Janahan has spoken on 3 investor events across 2 companies, most recently for Aktis Oncology, Inc. on May 27, 2026. Those appearances were for Aktis Oncology, Inc. (AKTS) and CRISPR Therapeutics AG (CRSP). The companies whose calls Alex Janahan spoke on are classified in the Healthcare sector.
“I guess for the company or the KOLs on the call, maybe just to put a finer point and maybe some numbers on a couple important questions that were mentioned. I guess first, based on the literature for B7H3 and other RLTs, I guess what delta would Do you want to see an uptake between tumor and normal tissues?”
“I guess for the company or the KOLs on the call, maybe just to put a finer point and maybe some numbers on a couple important questions that were mentioned. I guess first, based on the literature for B7H3 and other RLTs, I guess what delta would Do you want to see an uptake between tumor and normal tissues?”
“I cover CRISPR Therapeutics at Bank of America. Thanks for joining this session with CRISPR. And I'm pleased to introduce Sam Kulkarni, the Chief Executive Officer at CRISPR for this 30-minute fireside.”
Bank of America
Analyst
Transcript header (unverified)
AKTS
Biotechnology · Healthcare
